MLO1 Antibody

Contextual Clarification: MLO-Related Antibodies

The term "MLO" appears in multiple contexts:

• Mildew Resistance Locus O (MLO) Proteins: Integral membrane proteins in plants (e.g., Arabidopsis thaliana MLO2) that interact with calmodulin and influence pathogen resistance .

• MLH1 (MutL Homolog 1): A DNA mismatch repair protein targeted by monoclonal antibodies (e.g., MLH1 [4C9C7] Mouse mAb #3515) .

• Mcl-1 (Myeloid Cell Leukemia 1): An anti-apoptotic protein studied via antibodies like Sheep Anti-Human Mcl-1 (AF8281) .

No peer-reviewed studies or commercial products specifically referencing "MLO1 Antibody" were identified. Potential misalignments in nomenclature (e.g., MLO vs. MLH1/Mcl-1) may explain this gap.

MLH1 (4C9C7) Mouse Monoclonal Antibody

Research Applications:

• Used in colorectal cancer diagnostics to identify Lynch syndrome .

• Validated in Western blot using Raji and Ramos lymphoma cell lines .

Mcl-1 Antibody (AF8281)

Functional Insights:

• Critical for studying apoptosis regulation in Burkitt’s lymphoma .

• Demonstrated specificity via knockout cell line validation (Figure 1B in ).

Antibody Validation and Characterization

Recent efforts highlight the importance of rigorous antibody validation:

• KO Cell Line Validation: Gold standard for confirming specificity (e.g., Mcl-1 knockout A431 cells ) .

• Five Pillars of Antibody Validation: Genetic, orthogonal, independent antibody, recombinant, and immunocapture-MS strategies .

Example Workflow for Mcl-1 Antibody:

1. Western Blot: 0.5 µg/mL primary antibody + HRP-conjugated secondary antibody .

2. Knockout Control: Parental vs. Mcl-1 KO A431 lysates to confirm signal loss .

Broader Implications in Antibody Therapeutics

While "MLO1 Antibody" remains uncharacterized, advancements in monoclonal antibody (mAb) technology are evident:

• Clinical Trials: 2,066 mAb trials reported between 2014–2023, targeting cancer, immune disorders, and infections .

• Engineering Trends: Fc modifications (e.g., M252Y/S254T/T256E) to enhance half-life and effector functions .

Recommendations for Future Research

To address the absence of "MLO1 Antibody":

1. Nomenclature Review: Clarify whether "MLO1" refers to MLH1, Mcl-1, or plant MLO proteins.

2. Target Identification: Use high-throughput methods like PolyMap for epitope binning .

3. Collaborative Validation: Engage platforms like YCharOS for antibody specificity screening .